Differential Diagnosis of Acute Neural Cognitive Decline

Initial Clinical Assessment Framework

• The presence of fever with altered mental status, new seizures, or focal neurological signs should immediately raise suspicion for CNS infection, particularly viral encephalitis, requiring urgent investigation 1, 2
• Metabolic, toxic, and autoimmune causes must be considered early, especially when certain features are present 1, 2

Red Flags Suggesting Non-Infectious Encephalopathy

• History of similar episodes 1, 2, 3
• Symmetrical neurological findings 1, 2
• Myoclonus or asterixis (strongly suggests metabolic encephalopathy) 4, 1
• Absence of fever 1, 2
• Acidosis or unexplained negative base excess 1

Major Diagnostic Categories

1. Metabolic and Toxic Encephalopathies

• Hepatic encephalopathy presents with cognitive impairment and asterixis in cirrhotic patients, requiring exclusion through blood tests (ammonia, liver function) and assessment for precipitating factors 4
• The differential for asterixis specifically includes uraemia, hypercapnia, hypoglycaemia, hydroelectrolytic disorders, and certain drugs 4
• Essential metabolic workup includes blood glucose, electrolytes, renal function, liver function tests, thyroid function, vitamin B12, and inflammatory markers 4, 5

2. Infectious Causes

• Viral encephalitis classically presents with fever, altered behavior, personality changes, speech disturbances, and seizures 1
• Bacterial meningitis with lymphocytic pleocytosis can mimic viral encephalitis, particularly Listeria monocytogenes, tuberculous meningitis, and partially treated bacterial meningitis 6
• CSF interpretation is critical, with normal glucose with lymphocytic pleocytosis suggesting viral infection, and low CSF:plasma glucose ratio suggesting tuberculosis, fungal infection, or partially treated bacterial meningitis 6

3. Cerebrovascular Disease

• Poststroke cognitive impairment (PSCI) occurs in up to 60% of stroke survivors, with 38% having mild cognitive impairment and 7-41% having dementia 3, 7
• Key differentiating features include acute stepwise decline in cognition, focal neurological deficits, MRI evidence of acute infarction or hemorrhage, and risk factors such as hypertension, diabetes, and atrial fibrillation 3, 8

4. Autoimmune and Paraneoplastic Encephalitis

• Antibody-mediated encephalitis should be suspected with subacute presentation, orofacial dyskinesia, choreoathetosis, faciobrachial dystonia, intractable seizures, and hyponatremia 1, 6
• Specific conditions include anti-NMDA receptor encephalitis, limbic encephalitis, Hashimoto encephalopathy, and neuropsychiatric SLE 6

5. Alcohol-Related Cognitive Disorders

• Wernicke-Korsakoff syndrome must be differentiated from hepatic encephalopathy in cirrhotic patients with alcohol use, with key features including anterograde episodic memory impairment, visuoconstructive impairments, and critical glucose administration before thiamine 4, 9

6. Neurodegenerative Diseases

• Alzheimer's disease and other dementias typically present with temporospatial disorientation, anterograde episodic memory impairment, visuoconstructive impairments, word-finding problems, and progressive course without fluctuations 5, 8

7. Additional Considerations

• In cirrhotic patients, consider cerebral microangiopathy, sleep apnea syndrome, chronic infectious and autoimmune meningoencephalitis, and psychiatric disorders 4, 6, 8
• In stroke patients, consider poststroke depression, medication effects, sleep disorders, and hearing and vision impairments 3, 5, 6, 8

Essential Diagnostic Workup

• Blood tests should include complete metabolic panel, complete blood count, thyroid-stimulating hormone, vitamin B12, folate, inflammatory markers, and ammonia if hepatic encephalopathy is suspected 4, 5
• Brain imaging should include MRI, which is preferred over CT for detecting subtle abnormalities 5
• CSF examination should include cell count and differential, glucose and protein, lactate, and HSV PCR if encephalitis is suspected 1, 6
• EEG may help distinguish metabolic encephalopathy from seizure activity or specific patterns in encephalitis 4

Critical Pitfalls to Avoid

• Never administer glucose before thiamine in patients with suspected Wernicke-Korsakoff syndrome, as this can precipitate or worsen the condition 9
• Do not delay empiric antibiotics if bacterial meningitis cannot be definitively excluded; treatment should begin within one hour when suspected 6
• Recognize that hyperammonemia can occur without encephalopathy, so ammonia levels alone do not confirm hepatic encephalopathy 4
• In patients with metabolic syndrome and NAFLD, vascular dementia may coexist with or mimic hepatic encephalopathy 4

Evidence‑Based Key Findings for the Differential Diagnosis of Altered Sensorium

Clinical History Red Flags

• A history of prior similar episodes of altered mental status suggests metabolic or toxic etiologies rather than an acute infection. 10
• Symmetrical neurological deficits are more indicative of metabolic derangements than focal structural lesions. 10
• Absence of fever lowers the likelihood of an infectious cause, though infection cannot be completely excluded. 10
• Presence of systemic acid‑base disturbance (acidosis or alkalosis) points toward a metabolic encephalopathy. 10

Infectious Encephalopathy Indicators

• Fever combined with altered behavior, personality change, or new‑onset seizures should prompt urgent evaluation for viral encephalitis. 10
• Fever together with focal neurological signs raises suspicion for encephalitis or a brain abscess. 10
• Severe headache accompanied by nausea, vomiting, and fever is a classic presentation of infectious encephalitis. 10
• Herpes simplex virus (HSV‑1) encephalitis presents with fever in ≈ 90 % of cases, along with altered behavior, speech disturbances, and seizures; lack of fever does not rule out the diagnosis. 10
• Systemic sepsis can produce an encephalopathic picture without direct central nervous system infection. 10
• Empiric antimicrobial therapy (broad‑spectrum antibiotics and acyclovir) should be initiated promptly when bacterial meningitis or encephalitis cannot be excluded, without waiting for definitive diagnostics. 10

Structural Neurological Causes

• Intracranial hemorrhage (subdural, epidural, or intraparenchymal) is especially likely in patients receiving anticoagulant therapy or with recent head trauma. 11

Metabolic Encephalopathies

Hepatic Encephalopathy

• Cirrhotic patients with hepatic encephalopathy typically exhibit cognitive decline and asterixis. 11
• Common precipitating factors include gastrointestinal bleeding, infection, constipation, dehydration, and certain medications. 11
• Approximately 22 % of individuals with liver disease and suspected hepatic encephalopathy have alternative extra‑hepatic diagnoses such as infection, stroke, or subdural hematoma. 11
• Elevated ammonia levels alone do not confirm hepatic encephalopathy, as hyperammonemia may be present without clinical encephalopathy. 11

Other Metabolic Derangements

• Abnormal serum sodium (both hyponatremia and hypernatremia) can cause osmotic shifts leading to encephalopathy. 11
• Thyroid disorders (myxedema coma or thyrotoxic crisis) are recognized metabolic causes of altered mental status. 11

Recommended Laboratory Workup

• Simultaneous ordering of a comprehensive metabolic panel, complete blood count, liver function tests, thyroid‑stimulating hormone, vitamin B12, and inflammatory markers is advised when metabolic encephalopathy is suspected. 11
• Serum ammonia measurement should be obtained when hepatic encephalopathy is in the differential diagnosis. 11

Non‑Infectious Systemic Triggers

• Urinary tract infection and community‑acquired pneumonia are frequent precipitants of encephalopathy in older adults. 11

Cognitive Disorders Overlapping with Metabolic Encephalopathy

• In individuals older than 60 years, mild cognitive impairment may coexist with covert hepatic encephalopathy, yet functional independence is generally preserved. 11
• Post‑stroke cognitive impairment occurs in up to 60 % of stroke survivors; among these, 38 % have mild cognitive impairment and 7–41 % develop dementia. 11